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Two cellular proteins, membrane cofactor protein (MCP) and moesin, were reported recently to be 
functionally associated with the initiation of a measles virus infection. We bave analyzed the interaction of 
measles virus with cell surface proteins, using an overlay binding assay with cellular proteins immobilized on 
nitrocellulose. Among surface-biotinylated proteins from a human rectal tumor cellline (HRT), measles virus, 
was able to bind only to a 67-kDa proteinthat was identified as MCP. The virus recognized dift'erent isoforms 
of MCP expressed from human (HRT and HeLa) and simian (Vero) celllines. The binding of measles virus 
to MCP was abolished after cleavage of the disulfide bonds by reducing agents as weil as after enzymatic 
release of N-linked oligosaccharides. By contrast, removal of sialic acid or 0-linked oligosaccharides did not 
aft'ect the recognition of MCP by measles virus. These data indicate that the receptor determinant of MCP is 
dependent on a conformation of the protein that is maintained by disulfide bonds and N-glycans present in tbe 
complement binding domains. Our results are consistent with a roJe of MCP as primary attacbment site for 
measles virus in the initial stage of an infection. The functional relationship between MCP and moesin in a 
measles virus infection is discussed. 
Measles virus (MV) is an enveloped negative-strand RNA 
virus that contains two surface glycoproteins: the hemaggluti-
nin (H), responsible for attachment to cells as weil as for 
agglutination of erythrocytes, and the fusion protein (F). The 
entry of MV occurs by binding to specific protein receptors on 
the host cell and subsequent fusion of the viral with the plasma 
membrane, resulting in the release of the nucleocapsid into the 
cytoplasm (for a review, see reference 5). 
MV shows a very restricted host range: humans are the only 
naturally infected species. For the propagation of the virus in 
cell culture, human or simian cells can be used. Lack of 
suitable receptors may be responsible for the resistance of 
many cells from species other than higher primates, although 
MV can be adapted to cells of many species, with replication 
continuing on low Ievels. For many years the cellular counter-
parts in the binding reaction have remained elusive, although 
several studies have suggested some receptor candidates. The 
substance P receptor has been reported to promote the fusion 
activity of MV (13). Proteins of 20 and 35.5 kDa that were 
isolated from membranes of Vero cells and African green 
monkey erythrocytes were able to inhibit virus attachment, 
infectivity, and hemagglutination activity, but they have not 
been characterized further (15). Recently, conclusive evidence 
was presented that membrane cofactor protein (MCP; also 
designated CD46) is an MV receptor (11, 22, 25). After 
transfection of nonpermissive cells (mouse or hamster) with 
MCP cDNA, MV was able to infect these cells. MCP is a 
C3-binding membrane protein and inhibits complement acti-
vation on host cells. lt is widely expressed on human cells 
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examined but is absent from erythrocytes. Alternative splicing 
gives rise to different MCP isoformsthat di:ffer in both amino 
acid sequence and glycosylation (for a review, see reference 
21 ). In a recent report, another membrane protein, moesin, has 
been shown to be also linked with susceptibility of cells to MV 
infection (12). Moesin, a membrane-organizing extension 
spike protein, is largely localized at the inner side of the plasma 
membrane but also accessible to antibodies on the cell surface 
(12, 18). Treatment of cells with antibodies to moesin reduces 
the proliferation rate of smooth muscle cells (17). As described 
for MCP (27), moesin was found tobe downregulated on cells 
persistently infected with MV (12). Aßtibodies to both pro-
teins, CD46 as weil as moesin, inhibit the infection of cells with 
MV (12, 25). 
With the increasing information about virus receptors, it has 
become obvious for several viruses that more than one cellular 
surface component may be involved in the initial interaction 
between a virus and a cell. Evidence for this concept has been 
presented for human immunodeficiency virus (6, 8, 10, 14) and 
poliovirus (24, 31). To understand the molecular events during 
this early stage of infection, it is important to determine 
whether a proposed receptor is involved in the attachment of 
the virus to the cell or in the subsequent fusion reaction 
between the viral and cellular membrane. lf a receptor is 
required for virus binding, it has to be established whether this 
molecule directly interacts with the virus or whether it assists 
another surface component in accomplishing the attachment 
of the virion to the plasma membrane. 
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We have started to analyze the interaction of MV with 
cellular receptors (MCP and moesin) by establishing an in vitro 
binding assay. Here we show that MV can bind to MCP 
immobilized on nitrocellulose. We present evidence that disul-
fide bonds and glycosylation are critical for maintaining a 
conformation of MCP that is recognized by MV. 
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MATERIALS AND METHODS 
Cells and virus. HRT (human rectal tumor), HeLa (human 
cervical carcinoma), and Vero (African green monkey kidney) 
cells were propagated in Dulbecco's modified Eagle's minimal 
essential medium supplemented with 10% fetal calf serum. 
The Edmonston strain of MV was grown in Vero cells. Virus 
was harvested from the supernatant when 50 to 80% of the 
cells showed a cytopathic eft'ect. After clarification of the 
medium by low-speed centrifugation (3,000 X g, 20 min), virus 
was sedimented by ultracentrifugation at 100,000 X g for 90 
min. The pellet was suspended in phosphate-buft'ered saline 
(PBS) and again pelleted at 150,000 X g for 35 min. After 
resuspension in PBS, the partially purified virus concentrate 
was stored at - 80°C. 
Preparation of biotinylated MV glycoproteins. Freshly pre-
pared virus concentrate was labeled with sulfosuccinimidobi-
otin (S-NHS-biotin; Pierce) by a modification of the protocol 
described by Clayson et al. (9). Virus samples containing 1 mg 
of viral protein in 1 ml of PBS were added to 0.66 ml of 
S-NHS-biotin dissolved in dimethyl sulfoxide (120 J.Lg/ml) and 
incubated for 4 h at room temperature. After dilution with 
PBS, biotinylated virus was sedimented by ultracentrifugation 
(150,000 X g, 35 min). Following the biotinylation of virus, the 
viral glycoproteins were isolated. Biotinylated virus suspended 
in 800 J.LI of PBS was incubated in the presence of 5% 
n-octylglucopyranoside (Sigma) for 10 min at room tempera-
ture. After centrifugation for 10 min at 12,000 X g, the 
supernatant was further incubated for 20 min at 4°C. Following 
centrifugation for 30 min at 100,000 x g, the supernatant was 
layered on a sucrose gradient (5 to 30% [wt/wt] on a cushion of 
60% sucrose) in PBS containing 1% octylglycoside. After 
centrifugation for 17 h at 200,000 X g in an ·SW55.1 rotor 
(Beckman), fractions of 0.5 ml were collected from the bottom 
of the tube. The samples were analyzed by sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). To 
determine the fraction containing the MV glycoproteins, the 
gel was stained with Coomassie brilliant blue. To check the 
biotinylation, the polyacrylamide gel was blotted to nitrocellu-
lose and the biotinylated proteins were detected by incubation 
with streptavidin-biotinylated horseradish peroxidase complex 
(1 h) followed by an incubation with PBS-4-chloro-1-naph-
thol-H202 (500:100:1). The fractions used for the glycoprotein 
overlay protein binding assays (GOBPA) consisted predomi-
nantly of MV H protein. 
Isolation of biotinylated cell surface proteins. Cell surface 
proteins were labeled as described by Lisanti et al. (20). After 
repeated washings with ice-cold PBS containing 0.1 mM CaCI2 
and 1 mM MgC12 (PBS-C/M), cells were incubated twice with 
S-NHS-biotin in PBS-C/M (0.5 mglml) for 30 min at 4°C. After 
the treatment, the cells were washed once with PBS containing 
0.1 M glycine and four times with PBS. The cells were seraperl 
from the culture fl.ask into a solution of PBS containing 1 mM 
EDTA. After Iysis of the cells with radioimmunoprecipitation 
assay (RIPA) buffer (1% Triton, 1% sodium deoxycholate, 
0.1% SOS, 0.15 M NaCI, 10 mM EDTA, 1 mM phenylmeth-
ylsulfonyl fluoride, 10 mM iodoacetamide, 0.14 mg of aprotinin 
per ml, 20 mM Tris-HCI [pH 7.5]), the biotinylated proteins 
were precipitated by addition of 50 J.Ll of packed streptavidin-
agarose (Pierce ). Following an incubation for 2 h on ice, the 
precipitates were washed and eluted by boiling in electro-
phoresis sample buffer lacking mercaptoethanol. The proteins 
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were separated on an SDS-12% polyacrylamide gel under 
reducing or nonreducing conditions. Mter SDS-PAGE, the 
proteins were blotted to a nitrocellulose sheet. As described 
for the biotinylated MV glycoproteins, the biotinylated cell 
proteins were detected by incubation with streptavidin-biotin-
ylated horseradish peroxidase complex and peroxidase sub-
strate. 
Immunoprecipitation of MCP. Unlabeled or surface-biotin-
ylated cells were lysed with RIP A buffer, and immunoprecipi-
tation was carried out with a monoclonal antibody (MAb) 
directed against MCP: J4/48 (Dianova), GB24 (1), or TRA2-10 
(2). After an incubation for 2 h on ice, the mouse immuno-
globulins were precipitated by addition of 50 J.Ll of protein 
A-Sepharose (Sigma) preincubated with rabbit anti-mouse 
immunoglobulins. The precipitates were washed and either 
used for glycosidase treatments or, after boiling in sample 
buffer, subjected to SOS-PAGE. The proteins were separated 
on an SDS-12% polyacrylamide gel under nonreducing con-
ditions and blotted to nitrocellulose. 
Glycosidase treatments. For the removal of sialic acid, MCP 
bound toprotein A-Sepharose was incubated for 2 hat 37°C 
with 250 mU of neuraminidase from Vibrio cholerae (VCNA; 
Behring, Marburg, Germany). For the treatment with other 
glycosidases, MCP was eluted from the beads by heating at 
96°C in a 50 mM phosphate buffer (pH 7.0) containing 0.1% 
SDS. To release the N-linked oligosaccharides, the eluate was 
digested overnight with 1 U of N-glycosidase F (Boehringer, 
Mannheim, Germany) at 37°C. For the removal of 0-linked 
oligosaccharides, the eluate containing VCNA-treated MCP 
was incubated for 18 hat 37°C with 5.6 mU of 0-glycosidase 
(endo-a-N-acetylgalactosaminidase; Boehringer). Prior to SOS-
PAGE, the digested samples were boiled at 96°C for 5 min in 
sample buffer (0.1 M Tris-HCI [pH 6.8], 10% glycerol, 2% 
SDS) and electrophoresed in 12% polyacrylamide gels. After 
blotting to nitrocellulose, the digested proteins were analyzed 
byGOPBA. 
Binding assays. Binding of MV to proteins blotted to 
nitrocellulose was analyzed by a virus overlay protein binding 
assay (VOPBA) (7) or by a modified GOPBA with biotinylated 
MV glycoproteins. Prior to the binding assay, the nitrocellulose 
sheet was kept in a solution of 10% nonfat dry milk in 
phosphate-buft'ered saline (PBS) overnight at 4°C. Following 
three washes with PBS containing 0.1% Tween, the nitrocel-
lulose was incubated for 45 min at 4°C with 5 to 10 1-Lg of 
partially purified MV in 400 J.Ll of PBS-Tween (VOPBA) or 
with 10 ~g of biotinylated glycoproteins in PBS (GOPBA). In 
the VOPBA, bound MV was detected, after washing with 
PBS-Tween, with MAb K83 directed to the MV H protein 
(19) diluted 1:100 in PBS-Tween. After washing, the blot 
was incubated with horseradish peroxidase (POX)-conjugated 
anti-mouse immunoglobulins ( anti-mouse/POX) from rabbit 
(dilution 1:400 in PBS-Tween). In the GOPBA, the bound 
biotinylated glycoproteins were detected with streptavidin-
biotinylated POX (streptavidin/POX) complex (dilution 1:500 
in PBS-Tween). All incubation and washing steps were per-
formed at 4°C. The proteins recognized by MV or MV 
glycoproteins were stained by the detection of the bound POX 
by using the enhanced chemiluminescence system (ECL; Am-
ersham). The resulting lightemissionwas visualized by expo-
sure of the nitrocellulose to an autoradiography film (Hyper-
film ECL; Amersham ). 
Western immunoblotting. The semidry Western blot 
method (16) was performed by the modification described by 
Schultze et al. (30). MAb J4/48 (Dianova) at a dilution of 1:50 
in PBS-Tween was used to detect MCP on nitrocellulose 
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FIG. 1. Binding ofMV and J4/48 toproteins from HRT ceUs. HRT 
ceUs were surface biotinylated and lysed with RIP A buJfer. Proteins 
were separated by SOS-PAGE before (lane 1) and after (lane 2) 
precipitation with streptavidin-agarose. After blotting to nitroceUu-
lose, the immobilized proteins were used for a VOPBA (A) with MV 
or a Westein blot (B) with 14/48. Binding of virus or MAb, respec-
tively, was detected with an enzyme-linked immunoassay. The band of 
about 40 kDa in lane 1 of panel A is not virus specmc because it was 
also stained in the absence of virus. 
sheets. After incubation with anti-mouse/POX, the protein was 
visualized by ECL. 
RESULTS 
Binding of MV to a 67-:kDa surface protein from IIRT cells. 
We attempted to detect the direct binding of MV to cell 
surface proteins by using a VOPBA After surface biotinyla-
tion and Iysis of HRT cells, the cellular proteins were sepa-
rated by SDS-PAGE and blotted to nitrocellulose. The immo-
bilized proteins. were used for a binding assay with MV (Fig. 
lA) and for a Western blot with J4/48 (Fig. lB). H the cell 
lysate was directly analyzed, no specific binding of MV to any 
cellular protein could be detected (Fig. 1A, lane 1). However, 
if the biotinylated proteins were isolated with stt:eptavidin-
agarose, and thereby concentrated, a protein of 67 kDa wa8 
recognized (lane 2). As shown in Fig. 1B, J4/48 reacted with a 
protein of the same size, suggesting that virus and antibody 
bind both to the same protein. The antibody even recognized 
a weak band in the cell lysate (lane 1 ), indicating that the 
Western blQt ha8 a higher sensitivity than the VOPBA. 
As a control, surface proteins from a nonhuman cell line 
(Madin-Darby canine kidney cells) were isolated and also 
analyzed, but neither MV nor the MAb recognized any proteiri 
(data not shown). 
Binding .of MV and isolated glycoproteins to immunopre-
cipitated MCP. To ensure that the 67-kDa protein recognized 
in the VOi'BA was indeed MCP, the proteinwas immunopre-
cipitated from HRT celllysates with J4/48. After SDS-PAGE 
under nonreducing conditions and blotting to nitrocellulose, 
MCP was detected bothin a Western blot with J4/48 (Fig. 2, 
lane 2) and in a VOPBA with MV (Fig. 2, lane 3). In cantrast 
to the binding assay with HRT cell surface proteins (Fig. 1), 
the ass~y with immunoprecipitated MCP shows binding to both 
iritracellular and surface MCP (Fig. 2). The lower bandsthat 
were stained in af:ldition to the 67-kDa protein probably 
represent intracellular, incompletely processed forms of MCP. 
To determine whether the binding to MCP could also be 
detected with solubilized viral glycoprotein, a preparation of 
biotin-labeled MV glycoproteins containing predominantly H 
protein was used for a GOPBA (Fig. 2, lane 4). Like the 
virions, the isolated glycoprotein bound efficiently to the 
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FIG. 2. Binding of MV to isolated MCP. MCP was immunopre-
cipitated from HRT celllysates with 14/48, separated by SDS-PAGE, 
and blotted to nitrocellulose. The immobilized proteins were incu-
bated in the absence. (lane 1, control) or in the presence of J4/48 (lane 
2), MV (lane 3), or biotinylated MV glycoproteins (lane 4). The 
binding of antibody and virus (lanes 2 and 3) was detected by 
immunostaining with anti-mouse/POX. The binding of biotinylated 
glycoproteins (lane 4) was visualized with streptavidin/POX. 
67-kDa form of MCP. The lower-molecular-weight bands were 
recognized less efficiently and were detectable in the overlay 
binding assay only after Ionger exposure tim es (not shown ). 
The bands that can be seen at the top of the gel (lane 1 
[control], lane 2 [Western blot] and lane 3 [VOPBA]) are due 
to the MAbs used for immunoprecipitation ofMCP. Theywere 
recognized by the POX-labeled anti-mouse antiborlies that 
were necessary for immunostaining of bound virus and bound 
J4/48. The anti-mouse immunoglobulins were not used in the 
GOPBA (lane 4) because in this assay biotinylated viral 
glycoprotein was visualized by streptavidin/POX. The result 
from Fig, 2 indicates that MV directly interacts with MCP and 
that the binding is due to MV glycoproteins. 
Binding of MV to the nonreduced but not to the reduced 
form of MCP. To analyze the importance of the protein 
conformation of MCP for the binding of MV, biotinylated 
HRT cell surface proteins were isolated with streptavidin-
agarose and subjected to SDS-PAGE under nonreducing and 
reducing (5% mercaptoethanol) conditions. Both MV (Fig. 
3A) and J4/48 (Fig. 3B) recognized the nonreduced (lane 1) 
but not the reduced (lane 2) form of the 67-kDa protein. A 
faint staining of the reduced form in the Western blot was 
detected only when the exposure time was extended from 10 to 
45 s (Fig. 3B, lane 2'). Detection of biotinylated reduced and 
nonreduced MCP with streptavidin/POX showed that no deg-
radation bad taken place in the reduced sample ( data not 
shown). The result from Fig. 3 indicates that disulfide bonds 
are critical for maintaining a conformation of MCP that is 
recognized by MV as weil as by the MAb. 
Binding ofMV glycoprotein to MC:P from dil'erent celllines. 
To compare the binding of MV to MCP from different cells, 
three MAbs to MCP were used for immunoprecipitation of 
biotinylated surface MCP from three celllines (HRT, HeLa, 
and Vero). As shown in Fig. 4A, J4/48 used for the experiments 
described above precipitated MCP only from human cells, 
HRT and HeLa. MAb TRA2-10, known as an antibody specific 
for the SCR1 domain of MCP (1), showed the same reactivity 
pattem (Fig. 4B). Vero cells were also. included because they 
are infected by MV more efficiently than HRT or HeLa cells 
(data not shown). The antiborlies mentioned above failed to 
detect a protein in the monkey cell line. However, immuno-
precipitation with a third antibody, GB24, resulted in the 
precipitation of MCP from all three celllines (Fig. 4C). This 
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FIG. 3. Binding of MV and J4/48 to surface proteins after electro-
phoretic separation under nonreducing and reducing co~d~tions. S~r­
face proteins of HRT cells were biotinylated an~ prec1p1tated w1~h 
streptavidin-agarose. Precipitates were disrupted m sample buffer m 
the absence (lanes 1) or presence (lanes 2) of 5% mercaptoethanol, 
analyzed by SDS-PAGE, and blotted to nitrocellulose. (A) The blot 
was incubated with MV. (B) The blot was incubated with J4/48. 
Binding of virus or MAb was detected with an enzyme-linked immu-
noassay. The exposure times were 10 s for lanes 1 and 2 and 45 s for 
lane 2'. 
antibody is specific for the short consensus repeat (SCR) 3 and 
4 region of MCP (1). 
The three celllines appear to express different isoforms of 
MCP. On the surface of HRT cells, a 67-kDa proteinwas the 
major form and a 60-kDa protein was the minor form. On 
HeLa cells, two isoforms of about 55 and 65 kDa were 
expressed, the smaller form being more abundant than the 
larger one. On Vero cells, only a 60-kDa proteinwas detected. 
These restilts are similar to those of others analyzing human 
and primate cell lines ( 4, 23, 32). 
To determine whether there is a difference between the 
various MCP isoforms concerning the recognition by MV, a 
binding assay with the GB24 immunoprecipitates from HRT, 
HeLa, and Vero cells was performed. Nonbiotinylated cells 
were used for the immunoprecipitation, and biotinylated MV 
glycoproteins were used for the binding assay. Bound glyco-
protein was detected with streptavidin/POX. As shown in Fig. 
5, the MV glycoproteins recognized MCP from all three cell 
lines ( compare with Fig. 4C). The binding to the He La cell 
protein is somewhat weaker than the binding to MCP from 
HRT, although there were similar amounts of MCP precipi-
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FIG. 4. lmmunoprecipitation of MCP from different celllines with 
different MAbs. HRT (H), HeLa (He), and Vero (V) cells were 
surface biotinylated and lysed in RIPA buffer. lmmunoprecipitation 
was performed with J4/48 (A), TRA2-10 (B), and GB24 (C). The 
samples were separated by SOS-PAGE under nonreducing conditions 
and blotted to nitrocellulose. Biotinylated proteins were detected with 
streptavidin/POX. 
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FIG. 5. Binding of biotinylated MV glycoproteins to MCP from 
different cell lines. HRT (H), HeLa (He), and Vero (V) celllysates 
were immunoprecipitated with MAb GB24. The immunoprecipitates 
were separated by SOS-PAGE under nonreducing conditions a~d 
blotted to nitrocellulose. The binding of biotinylated MV glycoprotems 
was detected with streptavidin/POX. 
tated by GB24 from both cells ( compare Fig. 4C and 5). The 
binding to the less abundant 65-kDa isoform of HeLa cells is 
detectable after Ionger exposure times (not shown). 
Dependence of MV binding on tbe glycosylation of MCP. To 
analyze the importance of the carbohydrate moieties of MCP 
for the binding by MV, the protein was immunoprecipitated 
with J4/48 and treated with different glycosidases. VCNA was 
used for the removal of sialic acids. N-linked oligosaccharides 
were released by incubation with N-glycosidase F. 0-linked 
oligosaccharides were cleaved by treatment with VCNA and 
0-glycosidase ( neuraminidase was required because 0-glyco-
sidase acts only on desialylated oligosaccharides ). After SOS-
PAGE and blotting to nitrocellulose, the digested samples 
were analyzed in a binding assay with biotinylated MV glyco-
proteins (Fig. 6). Analysis of the digested samples by West~rn 
blotting confirmed that MCP bad not been degraded dunng 
the enzyme treatment (not shown). 
In the case of HeLa cells, the treatment of MCP with 
glycosidases led to a pronounced decrease in size (Fig. 6). The 
digestion of the 65- and 55-kDa isoforms with VCNA (lane 2) 
resulted in two proteins with estimated molecular masses of 55 
and 48 kDa, respectively, indicating a high degree of sialylation 
of the Hel...a MCP. Removal of the sialic acids improved the 
binding of the MV glycoprotein. Further digestion of the 
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FIG. 6. Binding of biotinylated MV glycoproteins to glycosidase-
treated MCP from HeLa cells. lmmunoprecipitated MCP was treated 
with different glycosidases: lane 1, untreated; lane 2, 250 mU of 
VCNA; lane 3, 1 U of N-glycosidase F; lane 4, 250 mU of VCNA and 
5.6 mU of 0-glycosidase. The digested samples were separated by 
SDS-PAGE under nonreducing conditions and blotted to nitrocellu-
lose. The blot was incubated with biotinylated MV glycoproteins, and 
binding was detected with streptavidin/POX. The arrows mark differ-
ent (undigested and digested) forms of MCP. 
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VCNA-treated MCP (55 and 48 kDa) with 0-glycosidase (lane 
4) resulted in a single broad protein band of about 48 kDa, 
indicating that only the upper band of MCP contained 0-
linked oligosaccharides. This result is in agreement with pre-
vious data that the difference between the isoforms is mainly 
due to variation in the amount of 0 glycosylation (3, 32). The 
0-glycosidase-treated MCP still carries N-linked oligosaccha-
rides and is recognized by MV glycoproteins as efficiently as 
the desialylated form. Treatment of HeLa MCP (65 and 55 
kDa) with N-glycosidase F resulted in two main forms of 47 
and 40 kDa (not shown). The upper band carries 0-glycans, 
whereas the lower band represents the deglycosylated form of 
MCP. The N-glycosidase F-treated HeLa MCP was not recog-
nized by MV glycoproteins (lane 3). 
Also, in the case of HRT cells, treatment with VCNA or with 
VCNA plus 0-glycosidase did not diminish the binding of MV 
glycoproteins to MCP, whereas treatment with N-glycosidase F 
abolished the recognition of MCP by MV (data not shown). To 
summarize, treatment of MCP with N-glycosidase F abolished 
virus binding; neuraminidase and 0-glycosidase did not dimin-
ish but rather improved the recognition of MCP by MV. 
DISCUSSION 
In this study, using in vitro binding assays, we have demon-
strated the direct binding of MV and MV glycoproteins to 
MCP (CD46). This membrane glycoprotein widely distributed 
throughout human tissue, normally binds complement factors 
(C3b and C4b), and protects the cell from complement-
mediated darnage (21, 28). The MCP gene is transcribed into 
multiple altematively spliced mRNAs coding for two groups of 
MCP isoforms with molecular masses of about 50 to 58 kDa 
and 59 to 68 kDa (29). The differences in molecular mass are 
mainly due to different 0 glycosylation. 0-linked oligosaccha-
rides are attached to membrane-proximal domains of MCP 
that are designated STPs, because they are enriched in serines, 
threonines, and prolines. Alternative splicing affects the num-
ber of STP regions ( one, two, or three) and concomitantly the 
number of 0-linked oligosaccharides. The three celllines used 
in this study express different MCP isoforms in different 
quantities. MV was found to bind to all of them. The HeLa 
MCP seemed to be recognized with lower efficiency than the 
other MCPs. The weak binding appears tobe due to the high 
extent of sialylation of HeLa MCP, because the removal of 
sialic acids improved the recognition of this protein by MV. 
We do not know whether the detrimelital effect of sialic acid is 
due to steric hindrance or due to the negative charge of this 
acidic sugar. Enzymatic release of the 0-linked oligosaccha-
rides did not diminish virus binding. Therefore, the STP 
domains including the 0-glycans appear not to be required for 
the recognition of MCP by MV. This finding is substantiated by 
the finding that the four primary isoforms of MCP all support 
MV infection (22). 
The receptor determinant is more likely located at the N 
terminus of the ectodomain which is composed of four repeat-
ing units designated SCR 1 to 4. These domains contain three 
N-linked oligosaccharides (on SCRs 1, 2, and 4) and are 
responsible for the binding of complement factors C3b and 
C4b as weil as for the cofactor activity of MCP (1). Specifically, 
SCRs 3 and 4 are required for C3b binding and SCRs 2 to 4 are 
required for C4b binding, while SCR 2 may play a special role 
in cofactor activity (21). MV is able tö recognize both human 
and simian MCP; i.e., its binding characteristics are similar to 
those of MAb GB24, which recognizes an epitope in the SCR 
3 and 4 domain. Future work is needed to determine whether 
this domain also contains the receptor deterrninant on MCP 
for attachment of MV. 
In contrast to 0 glycosylation, N-glycans appear to play an 
important role in the binding of MV to MCP. Release of 
N-linked oligosaccharides from MCP by treatment with N-
glycosidase F abolished the recognition by MV. The impor-
tance of N-linked carbohydrates bad been suggested by a 
previous study. Following inactivation of receptors by protease 
treatment, regeneration of receptors was prevented in the 
presence of tuncamycin, an inhibitor of N glycosylation (26). 
However, these authors have not shown whether the Iack of 
N-glycans directly affects the binding of MV or whether MCP 
lacking Asn-linked oligosaccharides is not transported to the 
cell surface or proteolytically degraded. Our results suggest 
that N glycosylation has a direct effect on the binding of MV to 
MCP. It is unlikely that the oligosaccharides themselves con-
stitute the receptor determinant, because this would require a 
unique carbohydrate structure present only on MCP. However, 
the N-glycans may be part of the receptor determinant. An-
other possibility is that MV recognizes a conforrnational 
protein domain that is maintained only in the presence of 
N-linked oligosaccharides. Carbohydrates are known to affect 
the conformation of glycoproteins. In the case of MCP, Iack of 
the three N-linked oligosaccharides is not expected to have a 
dramatic effect, because J4/48 interacted very efficiently with 
N-glycosidase F-treated MCP. This antibody recognizes a 
conformational epitope, as shown by its poor reactivity with the 
reduced form of MCP. MV also failed to recognize MCP after 
cleavage of the disulfides bonds, indicating that the receptor 
deterrninant on MCP is conformation dependent. Thus, our 
data indicate that MV binds to a conformational epitope of 
MCP that requires the presence of N-linked oligosaccharides. 
Our results are consistent with MCP constituting the pri-
mary attachment site for MV on the cell surface. At present we 
do not know the relationship between this virus receptor and 
moesin, another cellular protein involved in the initial stage of 
an MV infection. Among surface-biotinylated cellular proteins, 
MV was able to recognize only MCP, not a 75-kDa protein. 
The failure to detect binding to moesin does not exclude a 
direct interaction between MV and this protein. It may be 
explained by the poor biotinylation of moesin or by the low 
amount present on the cell surface. Binding assays with 
isolated protein are required to demoostrate the direct binding 
of MV to moesin. As MAbs to both MCP and moesin inhibit 
infection by MV (12, 26), it is unlikely that the two proteins 
function as alternative receptors. Our results favor a role for 
MCP as the primary attachment site for MV. It is conceivable 
that moesin plays a role in a postadsorption step. Altematively, 
MCP and moesin may interact with each other and form a 
complex that represents the actual receptor for MV. Future 
work is needed to determine the relationship between MCP 
and moesin with respect to an MV infection. 
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